In Sunovion Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc., No. 13-1335 (Fed. Cir. Sept. 26, 2013), the Federal Circuit reversed the district court’s grant of SJ of noninfringement, concluding that, although the district court did not err in construing the asserted claims, Sunovion Pharmaceuticals, Inc. ("Sunovion") was entitled to a judgment of infringement as a matter of law under 35 U.S.C. § 271(e)(2)(A).